SUMMARY. Plasma lactoferrin is an acute phase protein which may have a variety of roles in the anti-infective process. As the diagnosis of infection in infants is particularly difficult, measurement of this protein could make a useful contribution, however previous reference values for infants were unsatisfactory.
higher than those in adults at weeks 7 and II (267 ± 176 Jlg/L and 269 ±163 Jlg/L respectively) but not at week 15 (176± 165 Jlg/L). There were no differences between infants fed breastmilk and those fed on infant formulas. These findings are discussed in terms of the possible origin and role of lactoferrin in the newborn.
Lactoferrin is an acute phase protein with a role in the anti-infective process. I The small amount of the protein that is present in the plasma is released predominantly from circulating granulocytes in the process of'phagocytosis.! It binds iron avidly thereby possibly denying bacteria the free iron needed for multiplication;' as well as inhibiting lipid peroxidation," and affecting the adhesive properties of granulocyte membranes. ' The measurement of plasma lactoferrin may be useful as an indicator of infection in difficult situations such as the diagnosis of infection in infants where it may mimic a variety of metabolic abnormalities." Whilst measurement of plasma CRP has in some centres been shown to be a helpful marker of infection," this is not universal and othersI including ourselves have found it inconsistent. We therefore decided to evaluate plasma lactoferrin with a view to its ultimate use in diagnosis and monitoring of infection in infants.
Reference values for plasma lactoferrin in infants relating particularly to the immediate postnatal period are not available. To establish these we have set up a non-isotopic enzyme immunoassay for plasma lactoferrin based on that of Estevenon and Figarella" which has only a small specimen requirement and is therefore ideally suited for use in newborns. With it we have determined plasma lactoferrin in normal full term infants up to 15 weeks of age, and compared these values with those found in normal adults. We have also compared levels in exclusively breastfed infants with those receiving feeding formulas. Such studies are necessary for the future interpretation of plasma lactoferrin levels in full term and in preterm infants. 
Materials and methods

MATERIALS
METHODS
Production of antibody coated polystyrene beads
The required number of beads was placed in a glass universal container, washed with absolute ethanol, rinsed three times with phosphate buffered saline, and drained. Lactoferrin antibody solution (150 p.L per bead) was then poured steadily onto the beads which were mixed gently on an orbital mixer for an hour, then placed at +4°C overnight without further mixing. Next morning 500 p.L of myoglobin solution was added, mixed, and incubated at 37°C for 1·5 h. Following this the beads were washed three times with 10 ml phosphate-buffered saline. Labelled beads were kept satisfactorily in phosphatebuffered saline at +4°C.
Assay procedure
Into the required number of glass test tubes was pipetted 150 p.L 5% albumin solution and 10 p.L standards, controls and tests. To each tube was added one coated bead and these were incubated on an orbital mixer overnight at room temperature. The beads were washed with three times 4 mL distilled water, and to each was added 300 p.L anti-Iactoferrin enzyme conjugate solution. They were then incubated at 37°C for 1·5 h. Each bead was washed a further three times with 4 mL distilled water, and transferred to a polystyrene test tube. To each was added 300 p.L of 0-phenylenediamine solution followed by incubation in the dark at room temperature for 0·5 h.
1·5 mL 1·0 moljL HCl was added and the solutions mixed well. The absorbances were read at 480 nm. The lactoferrin concentrations of the tests were read from a standard graph.
ANALYTICAL EVALUATION
Linearity and reproducibility
The method was linear to 800 p.gjL lactoferrin using both lactoferrin standard and a plasma sample with a high lactoferrin concentration. A standard value 680 p.gjLgave a between run mean absorbance of 0·36 AU, standard deviation 0·038 (n = 8). Specimens giving values above 800 p.gjL were repeated after dilution with 5% albumin solution. The between batch coefficient of variation was 9·7% at a plasma lactoferrin value of344 p.gjL (n = 17) and 14·4% at a plasma lactoferrin value of 675 p.gjL (n=8).
Recovery of added lactoferrin
Recovery of lactoferrin was found to be between 96 and 99% at lactoferrin concentrations of between 260 and 422 p.gjL.
Choice of blocking agent
Though albumin was used initially for blocking unreacted sites on the beads, blank values remained unacceptably high. Use of myoglobin, chosen for its smaller molecular size, resulted in considerable reduction of blank values (Fig. 1) such that the minimum detectable concentration of lactoferrin (defined as twice the absorbance change of the blank) was 20 p.gjL.
Concentrations of antibody and conjugate
The dilution of lactoferrin antibody was chosen to give linearity over the range 20 to 800 p.gjL. Increase in the volume of conjugate used beyond that indicated in the method, was found not to increase sensitivity but to raise the value of the blank absorbance.
Incubation times
An overnight first incubation was found to be convenient and satisfactory. Incubation with anti-lactoferrin enzyme conjugate for 1·5 h was found to be optimal; a shorter incubation lowered sensitivity whilst a longer one resulted in loss of linearity (Fig. 2) .
Cross reactivity
Cross reactivity of the lactoferrin antibody was checked against both human transferrin and bovine lactoferrin both of which showed less than 5% cross reactivity.
Normal adults Venous blood specimens were obtained from 21 healthy members of the laboratory staff, 12 female and 9 male, age range 20-55 years. The blood was separated immediately and stored at -20°C until analysis. The mean adult plasma lactoferrin value was 122±4O J.l.g/L range 42-202 J.l.g/L. Capillary specimens were obtained from a similar group of 13 adults (6 female and 7 male). The blood was again separated immediately but the specimens were stored at +SoC overnight before analysis. Plasma lactoferrin values gave a mean of 107± 73 J.l.g/L with a range up to 253 J.l.g/ L.
Full term infants
For the study of plasma lactoferrin in the newborn, 175 capillary blood specimens were obtained, 65 from term babies being routinely investigated for neonatal jaundice (babies were 37 weeks gestation or over; birthweights were greater than 2·2 kg, no clinical signs of infection, total bilirubin less than 200 J.l.mol/L), the remainder from infants taking part in feeding studies (for which ethical committee approval and maternal consent were obtained).
The mean plasma lactoferrin from term infants up to the age of21 days was 385 ± 113J.l.g/L which was significantly higher than the value found in either venous or capillary blood from adults ('1'-test, P < 0,005). The distribution of results is shown in Fig 3. Here the three weeks' results are subdivided in an attempt to describe more closely the plasma concentrations of lactoferrin during the immediate postnatal period. These data were better described by use of logarithmically transformed data and the reference intervals shown are based on the mean ± 2SD of such transformed data. There was no significant trend with age though the scatter was greatest at the end of the first week and decreased towards the end of the third week.
Plasma lactoferrin values at 7,11 and IS weeks gave means of 267 ± 176 J.l.g/L (1'1=26), 269± 163 J.I./L (1'1=23), and 176± 165 J.l.g/L (1'1=21) respectively. The means at 7 and II weeks were significantly higher than those found in adults (P < 0·005 from adult capillary values), but that at 15 weeks was not. This is shown in 
FIG. 2. Effect oflength of the secondincubation(figures adjacent to curves) on the final absorbance at different concentrations of lactoferrin.
Effect of diet in full term infants
Specimens were obtained from infants undergoing a feeding study in which one group (1' 1 = IS) comprised entirely of breastfed babies were com- pared with a group (n = 17) comprised of babies fed entirely on infant feeding formulas (GoldCap or WhiteCap SMA, Wyeth International Ltd). There were no significant differences in birthweight, length, or gestational age. However, whilst all formula fed babies were delivered normally, two breastfed babies were delivered by Enzyme immunoassay is an appropriate technique for the measurement of plasma lactoferrin. The method developed for neonatal plasma was similar to that devised by Estevenon and Figarella" primarily for biological fluids such as human pancreatic juice, which had a comparatively narrow working range. Our method gave adult reference values for both venous and capillary plasma very similar to other published values-? but those from serum tend to be higher"!', Such values are obviously dependent on the calibration material and no universal standard is available at present. The range of the method described was particularly suitable for measurement oflactoferrin from capillary samples, and was able to accomodate the wide range of concentrations found in the plasma of neonates. Choice of a solid phase enzyme immunoassay based on the use of polystyrene beads means that the assay requires none of the specialised equipment required by microtitration plate methods. Plasma lactoferrin levels were measured in both fullterm infants and adults. Little information is available on lactoferrin levels in infants. Gutteberg et a/. 12 • IJ gave the upper limit of the normal for groups of unspecified newborn infants as about 16 mg/L and 19 mg/L which is considerably higher than our data.
It is generally accepted that in adults circulating plasma lactoferrin is derived predominantly from the neutrophil," being released during the process of phagocytosis as one of a number of intragranular proteins. This study has demonstrated that in term babies at birth the concentration of circulating lactoferrin is considerably higher than that found in adults. It could be argued that this is simply a reflection of the neutrophil leucocytosis present at birth." However the leucocytosis disappears over the first week of life in the majority of infants, though it may remain evident in a small number of apparently healthy babies. In most infants by the 10th day values are similar to those found in adults. This is not the case with plasma lactoferrin which remains high for a much longer period. In the present study differential white cell counts were not available so no direct comparison could be made.
forceps and one by caesarian section. Plasma lactoferrin values of these latter babies did not appear different from those of the rest of their group. There were no significant differences (' t'-test) between the means of breastfed and formula fed groups. We have shown that over the second month plasma lactoferrin begins to fall but that it is not until the end of the fourth month that values approach those found in adults. Even then a few infants retain high plasma lactoferrin values. Examination of our infant population failed to indicate why some infants should have maintained a high plasma lactoferrin level whilst in others it fell. These results indicate the difficulty of interpreting isolated lactoferrin results in the immediate postnatal period.
The concentration of lactoferrin in cow's milk and therefore in cow's milk based feeding formulas is low (20-200 mg/L") compared with that in human milk (7 giL in colostrum, not less than I g/ L in mature milk"), We were however unable to demonstrate that this had any affect on plasma lactoferrin levels in the newborn.
A study in adults with a variety of inflammatory conditions demonstrated that in disease the plasma lactoferrin concentration closely parallels the white count.' However, the magnitude of the relationship in the different conditions was not constant indicating that there must be other factors involved in determining the plasma lactoferrin content. Lactoferrin is cleared from the circulation in a matter of hours," clearance of iron saturated lactoferrin being more rapid than that of apolactoferrin. A close correlation between granulocyte turnover rate and plasma lactoferrin appeared to confirm that lactoferrin entering the circulation from other sources than granulocytes was insignificant.! yet there does not appear to be any direct correlation between individual neutrophil lactoferrin content and plasma lactoferrin concentration." There is evidence that the peak level of circulating lactoferrin precedes the peak in neutrophil count':" which has led to the interesting suggestion that some lactoferrin may come from bone marrow itself. It is possible that this could also be a source of the high lactoferrin found in normal term babies but further studies are necessary to clarify the situation.
